125 related articles for article (PubMed ID: 20639819)
21. Is long-term methimazole therapy as effective as radioiodine for treating hyperthyroidism?
Toft AD
Nat Clin Pract Endocrinol Metab; 2005 Nov; 1(1):14-5. PubMed ID: 16929359
[No Abstract] [Full Text] [Related]
22. Different strategies to overcome the effect of carbimazole on high- and low-dose radioiodine therapy: results from continuous dose-effect models.
Walter MA; Schindler C; Christ-Crain M; Müller-Brand J; Müller B
Eur J Clin Invest; 2009 Jan; 39(1):51-7. PubMed ID: 19087129
[TBL] [Abstract][Full Text] [Related]
23. Radioiodine treatment of hyperthyroidism. Success rate and influence of thyrostatic medication.
Ghadban WK; Zirie MA; Al-Khateeb DA; Jayyousi AA; Mobayedh HM; El-Aloosy AS
Saudi Med J; 2003 Apr; 24(4):347-51. PubMed ID: 12754531
[TBL] [Abstract][Full Text] [Related]
24. Effect of therapy on the serum thyroglobulin concentration in patients with toxic diffuse goiter, toxic nodular goiter and toxic adenoma.
Ericsson UB; Tegler L; Dymling JF; Thorell JI
J Endocrinol Invest; 1987 Aug; 10(4):351-7. PubMed ID: 2445808
[TBL] [Abstract][Full Text] [Related]
25. [131I-treatment of the autonomous toxic nodule. Assessment of a fixed dose protocol].
Abós MD; Banzo J; Razola P; García F; Prats E
Rev Esp Med Nucl; 1999 Dec; 18(6):431-5. PubMed ID: 10611569
[TBL] [Abstract][Full Text] [Related]
26. [Effect of antithyroid medication on the effective half-life and uptake of 131-iodine following radioiodine therapy].
Moka D; Voth E; Schicha H
Nuklearmedizin; 1997 Apr; 36(3):87-92. PubMed ID: 9162907
[TBL] [Abstract][Full Text] [Related]
27. Outcome of pediatric Graves' disease after treatment with antithyroid medication and radioiodine.
Ward L; Huot C; Lambert R; Deal C; Collu R; Van Vliet G
Clin Invest Med; 1999 Aug; 22(4):132-9. PubMed ID: 10497711
[TBL] [Abstract][Full Text] [Related]
28. Standard dose 131I therapy for toxic multinodular goiter in an endemic goiter region.
Gonçalves E; Castro JA; Gross JL
Braz J Med Biol Res; 1986; 19(6):723-9. PubMed ID: 3651625
[TBL] [Abstract][Full Text] [Related]
29. [Clinical aspects, diagnosis and drug therapy of hyperthyroidism].
Bürgi U; Gerber H; Peter HJ
Schweiz Med Wochenschr; 1995 Aug; 125(31-32):1489-94. PubMed ID: 7545825
[TBL] [Abstract][Full Text] [Related]
30. Efficacy of low and high fixed dose radioactive iodine therapy in patients with toxic nodular goiter.
Sonmez B; Erem C; Dogan I; Ersoz HO; Sonmez M
Minerva Endocrinol; 2011 Jun; 36(2):117-21. PubMed ID: 21519320
[TBL] [Abstract][Full Text] [Related]
31. [The management of thyrotoxicosis: a schematic approach].
Papi G; Carapezzi C; Corsello SM
Minerva Endocrinol; 2002 Jun; 27(2):119-26. PubMed ID: 11961503
[TBL] [Abstract][Full Text] [Related]
32. [Late results of treating thyrotoxicosis with 131I and post-therapeutic hypothyroidism].
Khelds AO; Ozols VK; Shtelmane IA
Med Radiol (Mosk); 1986 Mar; 31(3):24-7. PubMed ID: 2421127
[TBL] [Abstract][Full Text] [Related]
33. [Treatment of hyperthyroidism caused by Graves' disease or toxic multinodular goitre by radioiodine: over 80% cure retrospectively after one calculated dose].
Bakker SC; Zanin DE; Zweers EJ
Ned Tijdschr Geneeskd; 2002 Sep; 146(39):1837-41. PubMed ID: 12382370
[TBL] [Abstract][Full Text] [Related]
34. Comparison between TRH-stimulated TSH and basal TSH measurement by a commercial immunoradiometric assay in the management of thyroid disease.
De Rosa G; Testa A; Giacomini D; Carrozza C; Maussier ML; Valenza V; D'Errico GF
Q J Nucl Med; 1996 Jun; 40(2):182-7. PubMed ID: 8909104
[TBL] [Abstract][Full Text] [Related]
35. Safety and efficacy of administering 0.2 mg of recombinant human TSH for two consecutive days as an adjuvant to therapy with low radioiodine doses in elderly out-patients with large nontoxic multinodular goiter.
Giusti M; Cappi C; Santaniello B; Ceresola E; Augeri C; Lagasio C; Minuto F
Minerva Endocrinol; 2006 Sep; 31(3):191-209. PubMed ID: 17213787
[TBL] [Abstract][Full Text] [Related]
36. Expression of Bcl-2 family proteins in thyrocytes from young patients with immune and nonimmune thyroid diseases.
Bossowski A; Czarnocka B; Bardadin K; Urban M; Niedziela M; Dadan J
Horm Res; 2008; 70(3):155-64. PubMed ID: 18663316
[TBL] [Abstract][Full Text] [Related]
37. Drug treatment in thyroid disease.
Mills LC
Semin Drug Treat; 1974; 3(4):377-402. PubMed ID: 4132535
[No Abstract] [Full Text] [Related]
38. Thyrotoxicosis--treatment by I131 therapy and early prediction of hypothyroidism following this therapy.
Khanna CM; Jain SK; Walia RP
J Assoc Physicians India; 1994 Jan; 42(1):36-8. PubMed ID: 7836246
[TBL] [Abstract][Full Text] [Related]
39. Long-term follow-up study of radioiodine treatment of hyperthyroidism.
Metso S; Jaatinen P; Huhtala H; Luukkaala T; Oksala H; Salmi J
Clin Endocrinol (Oxf); 2004 Nov; 61(5):641-8. PubMed ID: 15521969
[TBL] [Abstract][Full Text] [Related]
40. [Results of radioiodine therapy of manifest hyperthyroidism and autonomous struma with euthyroidism].
Berding G; Schicha H
Nuklearmedizin; 1990 Aug; 29(4):158-65. PubMed ID: 2216811
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
